Article R5121-206
The detailed rules for the application of sections 1 to 12 of this chapter are determined as necessary, after obtaining the opinion of the Director General of the Agence nationale de sécurité du médic…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 10591–10600 of 36632 articles for “Art. al. 5”
The detailed rules for the application of sections 1 to 12 of this chapter are determined as necessary, after obtaining the opinion of the Director General of the Agence nationale de sécurité du médic…
…by reasoned decision, refuse to include a medicinal product on the list referred to in Article R. 5121-202 for any public health reason, in particular when the benefit/risk balance of the medicinal…
…r body mentioned in Article L. 4211-9-1 or the pharmaceutical establishment mentioned in Article L. 5124-1 or Article L. 5124-9-1 ; 3° The patient's surname, first name and date of birth; 4° The produ…
This article applies to the post-authorisation safety studies referred to in Article R. 5121-178 which are carried out either voluntarily by the holder of the marketing authorisation referred to in Ar…
…adverse reaction suspected to be due to a medicinal product or to a product mentioned in Article R. 5121-150, occurring in France, which has been reported or notified to it; 2° Report electronically t…
…he pictogram provided for in II or III which he uses, without applying the provisions of Article R. 5121-41. V.-In the event of non-compliance with the provisions of II, III and IV, the suspension of…
…parallel distribution in France of a proprietary medicinal product within the meaning of Article L. 5124-13-2, it shall inform the marketing authorisation holder of this intention and send the Directo…
When, in application of the second paragraph of Article L. 5124-11, the Director General of the Agence nationale de sécurité du médicament et des produits de santé intends to prohibit the export of a…
The operation, as defined in the second paragraph of 3° of Article R. 5124-2, of a proprietary medicinal product benefiting from a parallel import authorisation is carried out by the holder of this au…
The classification of a medicinal product in the category of medicinal products requiring special monitoring during treatment has the effect of making its prescription subject to periodic examinations…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More